Top Markets
Coin of the day
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Company

4016
Rang in Aktien #12222
Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh,... Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of generic medicines and various pharmaceutical products, from research and development to manufacturing and sales, catering to both local and international markets. Its business operations are strategically divided into private sector, public sector, and export divisions. MEPIC offers an extensive array of products designed to address a wide range of medical conditions. This includes dermatological treatments, remedies for respiratory ailments, central nervous system disorders, digestive issues, and musculoskeletal complaints, alongside medications for the urinary and reproductive systems. Furthermore, the company provides disinfectants and a diverse portfolio of therapeutic agents covering areas such as sexual health, diabetes, cardiovascular diseases, anti-infectives, anti-parasitics, pain relief, antiseptics, and general men's and women's health. These pharmaceutical and health products are supplied in numerous formats, including creams, ointments, syrups, capsules, tablets, gels, lotions, sprays, topical solutions, and personal hygiene items like hand sanitizers, mouthwashes, and soaps. In addition to its proprietary product lines, MEPIC leverages its manufacturing capabilities to offer contract manufacturing services. The company also specializes in cosmetic products, general health aids, and nutritional supplements. Originally known as Middle East Chemical Products Factory Company, the organization officially rebranded to Middle East Pharmaceutical Industries Company in January 2006.
Aktienkurs
$17.36
Zuletzt synchronisiert: 2026-08-30
Marktkapitalisierung
$607.55M
Veränderung (1 Tag)
0.54%
Veränderung (1 Jahr)
-10.39%
Land
SA
Handel Middle East Pharmaceutical Industries Company (4016)

Kategorie

Preis 4016 mit Marktkapitalisierung von B
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
4016
$17.36
Marktkapitalisierung von Middle East Pharmaceutical Industries Company(4016)
Marktkapitalisierung: $607.55M
Mit Stand August 2026 hat Middle East Pharmaceutical Industries Company eine Marktkapitalisierung von $607.55M. Das macht Middle East Pharmaceutical Industries Company laut unseren Daten zum 12222nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Middle East Pharmaceutical Industries Company von 2024 bis 2026
4016 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 4016 Vermögenswert B Marktkapitalisierung von B Ergebnisse
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$150,396 $607.55M
$5.264T +866,305.79%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$134,322 $607.55M
$4.701T +773,706.04%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$119,348 $607.55M
$4.177T +687,442.16%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$109,069 $607.55M
$3.817T +628,224.76%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$81,895.34 $607.55M
$2.866T +471,684.43%